Latest Health News

Tag: late-stage

  • Astrazeneca says Forxiga combination beats use of drug alone

    —

    by

    elegant
    in

    AstraZeneca said combining its Forxiga type-2 diabetes drug with older medicine Bydureon was more effective at controlling blood sugar levels than treatment with either drug on its own. In a late stage trial, Forxiga and Bydureon were tested on patients whose blood sugar levels could no longer be sufficiently kept in check under an initial…

  • Astrazeneca says Forxiga combination beats use of drug alone

    —

    by

    creative
    in

    AstraZeneca said combining its Forxiga type-2 diabetes drug with older medicine Bydureon was more effective at controlling blood sugar levels than treatment with either drug on its own. In a late stage trial, Forxiga and Bydureon were tested on patients whose blood sugar levels could no longer be sufficiently kept in check under an initial…

  • Cost-cutting deal with unions key to VW’s recovery

    —

    by

    publisher
    in

    By Andreas Cremer BERLIN (Reuters) – Volkswagen's ability to agree a big cost-cutting plan with its powerful labor unions in the coming weeks could determine whether the German carmaker's shares make a full recovery from its emissions scandal. A year after it admitted using illegal software to rig diesel emissions tests, Volkswagen (VW) has still…

  • Novo plans larger study after encouraging semaglutide results

    —

    by

    admin
    in

    By Nikolaj Skydsgaard COPENHAGEN (Reuters) – Novo Nordisk's experimental injectable diabetes drug semaglutide reduced cardiovascular risk by 26 percent, according to results released on Friday, paving the way for a new and bigger study on the drug's benefits. Semaglutide is the third diabetes drug to show such heart benefits, after Novo's Victoza injectable and Eli…

  • J&J leukemia drug cuts death risk vs. chemo in new patients: study

    —

    by

    publisher
    in

    Johnson & Johnson’s and AbbVie’s cancer drug Imbruvica significantly reduced the risk of death and disease progression compared with chemotherapy in previously untreated patients with a type of leukemia in a late stage study, paving the way for an expanded approval of the medicine. In the trial of 269 patients aged 65 and older with…